SSI Diagnostica Group Acquires InDevR
February 3, 2026
SSI Diagnostica Group has announced the acquisition of InDevR, a Colorado-based provider of multiplexed solutions for vaccine testing and quality control. The deal is intended to strengthen SSI’s leadership in pneumococcal vaccine QC testing by adding next-generation multiplexing assays, influenza and mRNA vaccine QC expertise, and related analytical software capabilities.
- Buyers
- SSI Diagnostica Group
- Targets
- InDevR
- Industry
- Healthcare Services
- Location
- Colorado, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.